Alnylam Pharmaceuticals (ALNY)

Add to Watchlists
Create an Alert
58.34 +2.61  +4.68% NASDAQ Apr 22, 8:00PM BATS Real time Currency in USD
View Full Chart
ALNY Price Chart
View All Events

ALNY Events

Date Type Description
Feb 13 Misc Alnylam Pharmaceuticals, Inc. Q4 2013 Earning Conference Call
Feb 13 Earnings Alnylam Pharmaceuticals, Inc. Q4 2013 Earning Result. Estimate: -0.48.
Jan 12 Misc Alnylam Acquires Investigational Rnai Therapeutic Assets From Merck
Nov 06 Misc Alnylam to Webcast Conference Call Discussing Third Quarter 2013 Financial Results
Nov 06 Earnings Alnylam Q3 2013 Release. Estimate: -0.38.
Aug 08 Misc Alnylam to Webcast Conference Call Discussing Second Quarter 2013 Financial Results
Aug 08 Earnings Second Quarter 2013 Financial Results. Estimate: -0.34.
Jun 06 Misc AGM Event for Alnylam Pharmaceuticals Inc
May 06 Misc Alnylam to Webcast Conference Call Discussing First Quarter 2013 Financial Results
May 06 Earnings Alnylam to Webcast Conference Call Discussing First Quarter 2013 Financial Results. Estimate: -0.31.
View All Performance Charts

ALNY Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Alnylam Pharmaceuticals is up 146.5% over the last year vs S&P 500 Total Return up 22.85%, Isis Pharmaceuticals up 69.65%, and Alexion Pharmaceuticals up 72.58%.

Get Quote for

PDF Report for ALNY

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download ALNY Pro Report PDF
Advertisement

Portfolio Strategies Featuring ALNY

Did Alnylam Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

ALNY Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.

Recent Quotes

Symbol Price Chg Chg % Market Cap
ALNY 58.34 +2.61 +4.68% 3.729B
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.